Yancui Wang

Yancui Wang

Auto-generated profile, based on publicly available information

Yancui Wang

Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2019 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
YWYancui Wang
Yancui Wang
KRKai Ren
Kai Ren
XLXinzhong Liao
Xinzhong Liao
GLGuanwen Luo
Guanwen Luo
KKKattareeya Kumthip
Kattareeya Kumthip
YCYongjun Chen
Yongjun Chen

23 April 2018 in Future Virology
Verified
Journal Article
Closed access
XLXinzhong Liao
Xinzhong Liao
YWYancui Wang
Yancui Wang
HYHaiyan Ye
Haiyan Ye
SLShilin Li
Shilin Li
LCLimin Chen
Limin Chen
XDXiaoqiong Duan
Xiaoqiong Duan
HCV chronically infects over 71 million people worldwide and is one of the leading causes of advanced liver diseases. Type I interferons (IFN-α/β) play critical role in host antiviral innate immunity. IFN-α/β exerts its anti-HCV effects through the activation of the JAK/STAT signaling pathway leading to the induction of a few hundred interferon-stimulated genes (ISGs). The interplay between ISG and HCV infection remains partially understood. In this review, we summarized the role of ISGs in HCV infection and interferon anti-HCV activity.